WashU Hematology Researchers Publish Findings on Anticoagulant Safety Gaps and Bleeding Risks

Recent publications from members of the Division of Hematology at WashU Med, emphasize the ongoing safety challenges of anticoagulant therapies in high-risk patient populations. “The first month after direct oral anticoagulants: a window of vulnerability” (published in Research and Practice in Thrombosis and Haemostasis), is commentary from Amber Afzal, MD, MSCI on direct oral anticoagulants (DOACs). “Anticoagulant […]

In Memoriam: Katherine Parker Ponder, MD (Links to an external site)

We are deeply saddened by the passing of Dr. Katherine Ponder. During her time spent at WashU Hematology, she was a pioneering expert in gene therapy whose research advanced the treatment of hemophilia. Her decades of scientific research made a profound, lasting impact on both patient care and the broader research community. Dr. Ponder will be greatly missed as an esteemed colleague and friend.